UNCY Unicycive Therapeutics4.84+0.15 (+3.2%)
UNCY Unicycive Therapeutics4.18-3.52 (-45.7%)
Premarket Decliner
UNCY Unicycive Therapeutics7.70+0.57+8.0%
Premarket:4.80-2.90 (-37.7%)
Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA)
Globe NewswireTue, 30-Jun 7:05 AM
UNCY Unicycive Therapeutics6.95-1.26 (-15.4%)
UNCY Unicycive Therapeutics7.42+0.40 (+5.7%)
UNCY Unicycive Therapeutics7.49+0.33 (+4.6%)